New 2025 Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study Group Paediatric Diseases Working Party (PDWP) 1st listed author A Bertaina Journal Bone Marrow Transplant.
New 2025 Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia Group Infectious Diseases Working Party (IDWP) 1st listed author Dina Averbuch Journal Lancet Infect Dis.
New 2025 Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Marta Villalba Journal Bone Marrow Transplant.
New 2025 Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
New 2025 Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Bone Marrow Transplant.
New 2025 Neglected tropical diseases (NTDs) and related infections in hematopoietic cellular therapy (HCT) in adults and children: a survey from the Infectious Diseases Working Party (IDWP) of the European Society of Blood and Marrow Transplantation (EBMT) Group Infectious Diseases Working Party (IDWP) 1st listed author John A Snowden Journal Bone Marrow Transplant.
New 2025 Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Kordelia Barbullushi Journal Bone Marrow Transplant.
New 2025 Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Vanderson Rocha Journal Bone Marrow Transplant.
2025 Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2025 Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP Group Paediatric Diseases Working Party (PDWP) 1st listed author Andre Manfred Willasch Journal Bone Marrow Transplant.
2025 Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2025 Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Patryk Sobieralski Journal Bone Marrow Transplant.